Literature DB >> 12590963

Amoebapores, archaic effector peptides of protozoan origin, are discharged into phagosomes and kill bacteria by permeabilizing their membranes.

Jörg Andrä1, Rosa Herbst, Matthias Leippe.   

Abstract

Antimicrobial peptides are widespread in animal species and their function as defensive molecules may even have appeared before the evolution of metazoa. The amoeboid protozoon Entamoeba histolytica discharge membrane-permeabilizing polypeptides named amoebapores into the phagosome in which engulfed bacteria are situated as evidenced here by confocal laser microscopy and electron microscopy using specific antibodies. We demonstrate that the purified three isoforms of the amoebic polypeptides exhibit complementary antibacterial activities in vitro. The potency of amoebapores were compared with that of antimicrobial peptides of phylogenetically widespread species by monitoring in parallel their activities against representatives of gram-positive and gram-negative bacteria and liposomes in various assays, and differences in the mechanism of membrane permeabilization became apparent. Northern blot analysis revealed that expression of genes coding for amoebapores and amoebic lysozymes is not dramatically changed upon co-culture of amoebae with bacteria indicating that the antimicrobial arsenal is rather constitutively expressed than induced in these primitive phagocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12590963     DOI: 10.1016/s0145-305x(02)00106-4

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  21 in total

1.  Natural History of Innate Host Defense Peptides.

Authors:  A Linde; B Wachter; O P Höner; L Dib; C Ross; A R Tamayo; F Blecha; T Melgarejo
Journal:  Probiotics Antimicrob Proteins       Date:  2009-12       Impact factor: 4.609

Review 2.  Evolution of Cell-Autonomous Effector Mechanisms in Macrophages versus Non-Immune Cells.

Authors:  Ryan G Gaudet; Clinton J Bradfield; John D MacMicking
Journal:  Microbiol Spectr       Date:  2016-12

3.  Proteomic analysis of phagocytosis in the enteric protozoan parasite Entamoeba histolytica.

Authors:  Mami Okada; Christopher D Huston; Barbara J Mann; William A Petri; Kiyoshi Kita; Tomoyoshi Nozaki
Journal:  Eukaryot Cell       Date:  2005-04

Review 4.  A short guided tour through functional and structural features of saposin-like proteins.

Authors:  Heike Bruhn
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

Review 5.  Tissue destruction and invasion by Entamoeba histolytica.

Authors:  Katherine S Ralston; William A Petri
Journal:  Trends Parasitol       Date:  2011-03-26

6.  Structure and function of a unique pore-forming protein from a pathogenic acanthamoeba.

Authors:  Matthias Michalek; Frank D Sönnichsen; Rainer Wechselberger; Andrew J Dingley; Chien-Wen Hung; Annika Kopp; Hans Wienk; Maren Simanski; Rosa Herbst; Inken Lorenzen; Francine Marciano-Cabral; Christoph Gelhaus; Thomas Gutsmann; Andreas Tholey; Joachim Grötzinger; Matthias Leippe
Journal:  Nat Chem Biol       Date:  2012-11-11       Impact factor: 15.040

Review 7.  Chew on this: amoebic trogocytosis and host cell killing by Entamoeba histolytica.

Authors:  Katherine S Ralston
Journal:  Trends Parasitol       Date:  2015-06-09

Review 8.  Host-microbe interactions and defense mechanisms in the development of amoebic liver abscesses.

Authors:  Julien Santi-Rocca; Marie-Christine Rigothier; Nancy Guillén
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

9.  Membrane permeabilization by trypanosome lytic factor, a cytolytic human high density lipoprotein.

Authors:  John M Harrington; Sawyer Howell; Stephen L Hajduk
Journal:  J Biol Chem       Date:  2009-03-26       Impact factor: 5.157

10.  Cysteine protease-binding protein family 6 mediates the trafficking of amylases to phagosomes in the enteric protozoan Entamoeba histolytica.

Authors:  Atsushi Furukawa; Kumiko Nakada-Tsukui; Tomoyoshi Nozaki
Journal:  Infect Immun       Date:  2013-03-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.